Infection and Immunity · 2002 · 143 citations · 43 references
Life SciencesCell BiologyMolecular BiologyInflammationMetabolic RegulationSignal TransductionCholesterol BiosynthesisCholesterol MetabolismLipid MetabolismLipid TransportLipoprotein MetabolismSterol MetabolismAtp-binding Cassette TransportersCholesterol AccumulationCholesterol EffluxHigh-density Lipoprotein MetabolismLipoprotein Metabolism RegulationLipoprotein ReceptorsLipoprotein-mediated TransportSterol Transporters
Lipopolysaccharide (LPS) has recently been shown to facilitate macrophage foam cell formation and has been suggested to be a proatherogenic factor. The mechanism of LPS induced cholesterol accumulation, however, is unclear. In this report, using the macrophage-like RAW 264.7 cell line, we provide experimental evidence that LPS's proatherogenic effects may at least in part reflect altered cholesterol metabolism. Data presented demonstrate that in a dose-dependent manner, LPS is able to down regulate the mRNA expression of the two primary high-density lipoprotein (HDL) receptors, scavenger receptor B1 (SR-B1) and ATP binding cassette A1 (ABCA1), with a 50% inhibitory concentration of less than 0.2 ng/ml, as well as to decrease SR-B1 protein expression by 80%. We also found that LPS treatment resulted in a significant decrease (to 20% of the control level) of the specific (125)I-HDL binding as well as in 50% inhibition of the HDL-mediated cholesterol efflux compared to untreated cells. In addition, we compared the potencies of various modified LPS preparations and demonstrated that the phosphorylated lipid A portion of LPS, which is highly conserved among gram-negative microorganisms, including Chlamydia, is primarily responsible for the effects of LPS on SR-B1 and ABCA1 expression. Inhibitors of NF-kappaB activation were observed to efficiently block the suppressive effect of LPS on SR-B1 and ABCA1, suggesting a mechanism involving NF-kappaB. These data indicate that the LPS effects on cholesterol metabolism may contribute to the proatherogenic properties of LPS.
43
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Susan Acton, Attilio Rigotti, Katherine T. Landschulz et al. · Science · 1996 · 2.3K citations
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
Ruey‐Bing Yang, Melanie R. Mark, Alane Gray et al. · Nature · 1998 · 1.2K citations